|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||4.3915 - 4.5500|
|52 Week Range||3.8500 - 11.2500|
|Beta (3Y Monthly)||0.16|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
On a per-share basis, the Montreal-based company said it had a loss of 2 cents. Earnings, adjusted for amortization costs, came to less than 1 cent on a per-share basis. The metabolic disorder drug company ...
MONTREAL (AP) _ Theratechnologies Inc. (THERF) on Thursday reported a loss of $978,000 in its fiscal fourth quarter. On a per-share basis, the Montreal-based company said it had a loss of 2 cents. The metabolic disorder drug company posted revenue of $13.8 million in the period.
NEW YORK, NY / ACCESSWIRE / February 21, 2019 / Theratechnologies Inc. (OTC PINK: THERF) will be discussing their earnings results in their 2018 Fourth Quarter Earnings to be held on February 21, 2019 ...
CORAL GABLES, FL / ACCESSWIRE / October 29,2018 / Frost & Sullivan will be hosting a Growth Innovation Leadership (GIL) briefing titled "2019 Healthcare Predictions Unleashed - Growth Opportunities, Technology, and Trends." The firm already states that Globally, 2019 will be a year of value-based care as we expect the outcomes-based care focus to globalize. "The HealthVue patient app powered by Reliq Health's technology platform will allow patients to book appointments, see their GP or a specialist via telemedicine, review their own chart, chat with clinic staff and pharmacists, refill prescriptions and share health data collected in the home with their HealthVue care team," said Dr. Essam Hamza, MD, CEO of HealthVue.
On a per-share basis, the Montreal-based company said it had net income of less than 1 cent. Earnings, adjusted for amortization costs, were 2 cents per share. The metabolic disorder drug company posted ...
If you want to know who really controls Theratechnologies Inc (TSE:TH), then you’ll have to look at the makeup of its share registry. Institutions often own shares in more establishedRead More...